iShares Nasdaq Biotechnology (IBB) option IV at low end of range

iShares Nasdaq Biotechnology (NASDAQ: IBB) 30-day option implied volatility is at 14; compared to its 52-week range of 14 to 35 after President Biden unveils first 10 drugs subject to Medicare price negotiation.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• Intel (INTC) call put ratio 1.2 calls to 1 put as share price up 6.7%
• OpenLane (OPLN) 6100 contracts of June 40 calls as share price up 3.9%